Preventing drug recalls involves stringent quality control measures during the manufacturing process. Pharmaceutical companies must adhere to Good Manufacturing Practices (GMP) to minimize the risk of contamination and other defects. Regular audits and inspections by regulatory bodies also play a crucial role in ensuring the safety and efficacy of cancer drugs.
